Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.46 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.46 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.46 |
| ▸ | GAPDH | P04406 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.46 |
| ▸ | STAT6 | P42226 | 1/20 | 0.46 |
| ▸ | PI4KA | P42356 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.46 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.46 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.46 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL98801 | 1.00 | SLC29A1 (0.56) | SLC29A1ADORA3ADORA1DPP4MEN1 | |
| SCHEMBL646509 | 0.87 | BCHE (0.46) | SLC29A1ADORA3ADORA1DPP4MEN1 | |
| SCHEMBL9851706 | 0.87 | SLC29A1 (0.44) | SLC29A1ADORA3ADORA1DPP4MEN1 | |
| SCHEMBL9851713 | 0.87 | SLC29A1 (0.44) | SLC29A1ADORA3ADORA1DPP4MEN1 | |
| SCHEMBL21565111 | 0.87 | SLC29A1 (0.53) | SLC29A1ADORA3ADORA1DPP4MEN1 | |
| SCHEMBL24538657 | 0.86 | SLC29A1 (0.55) | SLC29A1ADORA3ADORA1DPP4MEN1 | |
| Cordycepin SCHEMBL21562220 | 0.86 | ADORA3 (0.63) | SLC29A1ADORA3ADORA1DPP4MEN1 | |
| Cordycepin SCHEMBL21591024 | 0.86 | ADORA3 (0.63) | SLC29A1ADORA3ADORA1DPP4MEN1 | |
| Cordycepin SCHEMBL24220702 | 0.86 | ADORA3 (0.63) | SLC29A1ADORA3ADORA1DPP4MEN1 | |
| Cordycepin SCHEMBL22081032 | 0.86 | ADORA3 (0.63) | SLC29A1ADORA3ADORA1DPP4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12312625-B2 | Engineering strain producing cordycepin and its derivative 3′-deoxyinosine, its preparation method and application | DALIAN UNIVERSITY (CN) | 2025-05-27 | — | — | US | claimed |
| US-20240344099-A1 | ENGINEERING STRAIN PRODUCING CORDYCEPIN AND ITS DERIVATIVE 3'-DEOXYINOSINE, ITS PREPARATION METHOD AND APPLICATION | DALIAN UNIVERSITY (CN) | 2024-10-17 | — | — | US | claimed |
| WO-2023206604-A1 | ENGINEERED STRAIN FOR PRODUCING CORDYCEPIN AND DERIVATIVE 3'-DEOXYINOSINE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF | 大连大学 | 2023-11-02 | — | — | WO | claimed |
| CN-114921354-B | Engineering strain for producing cordycepin and derivative 3' -deoxyinosine thereof as well as preparation method and application thereof | 大连大学 | 2023-08-25 | — | — | CN | claimed |
| CN-114921354-A | Engineering strain for producing cordycepin and derivative 3' -deoxyinosine thereof as well as preparation method and application thereof | 大连大学 | 2022-08-19 | — | — | CN | claimed |
| US-11021497-B2 | Compositions and methods for synthesis of phosphorylated molecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-06-01 | — | — | US | claimed |
| CN-107974476-B | Biotransformation method for converting cordycepin into 3' -deoxyinosine | 中国科学院沈阳应用生态研究所 | 2020-12-29 | — | — | CN | claimed |
| US-20200239500-A1 | Compositions and Methods for Synthesis of Phosphorylated Molecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-07-30 | — | — | US | claimed |
| WO-2020063262-A1 | APPLICATION OF 3'-DEOXYINOSINE IN PREPARATION OF DRUG, FOOD OR HEALTH PRODUCT FOR MULTIPLE DISEASE | SHENZHEN SUNNY BIO-TECHNOLOGY.CO., LTD (CN) | 2020-04-02 | — | — | WO | claimed |
| CN-109260217-A | 3`- deoxyinosine nucleosides is in preparation for the application in a variety of disease drugs, food or health care product | 深圳松乐生物科技有限公司 | 2019-01-25 | — | — | CN | claimed |
| US-7807653-B2 | Nucleotide mimics and their prodrugs | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2010-10-05 | — | — | US | claimed |
| US-20070265224-A1 | Nucleotide mimics and their prodrugs | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2007-11-15 | — | — | US | claimed |
| US-20040059104-A1 | Nucleotide mimics and their prodrugs | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2004-03-25 | — | — | US | claimed |
| US-6316228-B1 | Efficient synthesis of nucleosides | THE UNIVERSITY OF IOWA RESEARCH FOUNDATION | 2001-11-13 | — | — | US | claimed |
| EP-0090417-B1 | PROCESS FOR PRODUCING 3'-DEOXYGUANOSINE | Yamasa Shoyu Kabushiki Kaisha (JP) | 1989-03-01 | — | — | EP | claimed |
| US-4594321-A | Reacting guanine derivative with phosphate | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1986-06-10 | — | — | US | claimed |
| US-4594320-A | Reacting guanine derivative with phosphate compound | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1986-06-10 | — | — | US | claimed |
| EP-0090417-A2 | Process for producing 3'-deoxyguanosine | Yamasa Shoyu Kabushiki Kaisha (JP) | 1983-10-05 | — | — | EP | claimed |
| JP-61146194-A | — | — | None | — | — | JP | disclosed |
| EP-0090417-A2 | Process for producing 3'-deoxyguanosine | Yamasa Shoyu Kabushiki Kaisha (JP) | 1983-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265224-A1 | Nucleotide mimics and their prodrugs | NUDT14, ENTPD5, MTAP | SLC29A1 19/4885ADORA3 95/4885ADORA1 91/4885 |
| US-20200239500-A1 | Compositions and Methods for Synthesis of Phosphorylated Molecules | PIK3CA, CHAMP1, TYMP | SLC29A1 498/4885ADORA3 729/4885ADORA1 1078/4885 |
| US-11021497-B2 | Compositions and methods for synthesis of phosphorylated molecules | PIK3CA, CHAMP1, TYMP | SLC29A1 498/4885ADORA3 729/4885ADORA1 1078/4885 |
| US-20040059104-A1 | Nucleotide mimics and their prodrugs | NUDT14, ENTPD5, MTAP | SLC29A1 19/4885ADORA3 95/4885ADORA1 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.